Cargando…
Radiofrequency ablation of stage IA non–small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial
BACKGROUND: A prospective multicenter phase II trial to evaluate the survival outcomes of percutaneous radiofrequency ablation (RFA) for patients with stage IA non-small cell lung cancer (NSCLC), ineligible for surgery. METHODS: Patients with a biopsy-proven stage IA NSCLC, staging established by a...
Autores principales: | Palussière, J., Chomy, F., Savina, M., Deschamps, F., Gaubert, J. Y., Renault, A., Bonnefoy, O., Laurent, F., Meunier, C., Bellera, C., Mathoulin-Pelissier, S., de Baere, T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109264/ https://www.ncbi.nlm.nih.gov/pubmed/30143031 http://dx.doi.org/10.1186/s13019-018-0773-y |
Ejemplares similares
-
Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases
por: de Baère, T., et al.
Publicado: (2015) -
Percutaneous Radiofrequency Ablation of Thyroid Carcinomas Ineligible for Surgery, in the Elderly
por: Marcy, Pierre Yves, et al.
Publicado: (2023) -
Determination of Interactive States of Immune Checkpoint Regulators in Lung Metastases after Radiofrequency Ablation
por: Miles, James, et al.
Publicado: (2022) -
Suivi de la réponse sérologique au virus SARS-CoV-2 chez des professionnels de santé d'un centre de lutte contre le cancer dans un contexte de pandémie de COVID19 (PRO-SERO-COV)
por: Cantarel, C., et al.
Publicado: (2022) -
Choice of Treatment for Stage IA Non-small Cell Lung Cancer Patients Ineligible for Surgery: Ablation or Stereotactic Body Radiotherapy?
por: Liang, Long, et al.
Publicado: (2020)